BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19120391)

  • 1. Recall injection-site reactions to etanercept in a patient with psoriasis.
    Papadavid E; Makris M; Dalamaga M; Kalogeromitros D; Stavrianeas N
    Clin Exp Dermatol; 2009 Apr; 34(3):414-5. PubMed ID: 19120391
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulomatous tattoo reaction in a patient treated with etanercept.
    Bachmeyer C; Blum L; Petitjean B; Kemiche F; Pertuiset E
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):550-2. PubMed ID: 17373994
    [No Abstract]   [Full Text] [Related]  

  • 3. Psoriasis after treatment of juvenile idiopathic arthritis with etanercept.
    Peek R; Scott-Jupp R; Strike H; Clinch J; Ramanan AV
    Ann Rheum Dis; 2006 Sep; 65(9):1259. PubMed ID: 16905590
    [No Abstract]   [Full Text] [Related]  

  • 4. Transient and reversible thrombocytopenia in a psoriatic patient treated with etanercept.
    Balato N; Gallo L; Gaudiello F; Chiurazzi F; Ayala F
    J Dermatolog Treat; 2010 Mar; 21(2):117-8. PubMed ID: 19634045
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy study on etanercept in patients with plaque psoriasis.
    Costanzo A; Mazzotta A; Papoutsaki M; Nisticò S; Chimenti S
    Br J Dermatol; 2005 Jan; 152(1):187-9. PubMed ID: 15656833
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe hypoglycemia after initiation of anti-tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus.
    Wambier CG; Foss-Freitas MC; Paschoal RS; Tomazini MV; Simão JC; Foss MC; Foss NT
    J Am Acad Dermatol; 2009 May; 60(5):883-5. PubMed ID: 19389539
    [No Abstract]   [Full Text] [Related]  

  • 7. Etanercept-induced asthma in a psoriatic patient resolving with transition to ustekinumab.
    Torres T; Vilaça S; Velho G; Selores M
    Eur J Dermatol; 2012; 22(5):696-7. PubMed ID: 22910198
    [No Abstract]   [Full Text] [Related]  

  • 8. Nicolau syndrome following etanercept administration.
    Guarneri C; Polimeni G
    Am J Clin Dermatol; 2010; 11 Suppl 1():51-2. PubMed ID: 20586511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous aspergillosis complicating tumor necrosis factor-α blockade therapy in a patient with psoriasis.
    Osório F; Magina S; Azevedo F
    Actas Dermosifiliogr; 2012 Dec; 103(10):939-41. PubMed ID: 23182382
    [No Abstract]   [Full Text] [Related]  

  • 10. Psoriasis induced by anti-tumor necrosis factor therapy: a class effect?
    Richette P; Viguier M; Bachelez H; Bardin T
    J Rheumatol; 2007 Feb; 34(2):438-9. PubMed ID: 17304662
    [No Abstract]   [Full Text] [Related]  

  • 11. Transient paresis of the right recurrent laryngeal nerve after treatment with etanercept for plaque-type psoriasis.
    Fiala K; Schierl M; Breier F; Feldmann R; Sator PG
    Eur J Dermatol; 2010; 20(6):818-9. PubMed ID: 20923747
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of von Zumbusch generalized pustular psoriasis with cyclosporine after eruption post etanercept injection.
    Ephrem G; Jour G; Smith BL
    J Med Liban; 2011; 59(3):168-9. PubMed ID: 22259908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recall injection-site reactions associated with etanercept therapy: report of two new cases with immunohistochemical analysis.
    González-López MA; Martínez-Taboada VM; González-Vela MC; Blanco R; Fernández-Llaca H; Rodríguez-Valverde V; Val-Bernal JF
    Clin Exp Dermatol; 2007 Nov; 32(6):672-4. PubMed ID: 17953638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral Candida chorioretinitis following etanercept treatment for hidradenitis suppurativa.
    Arriola-Villalobos P; Díaz-Valle D; Alejandre-Alba N; López-Abad C; Méndez-Fernández R; Benítez-del-Castillo JM
    Eye (Lond); 2008 Apr; 22(4):599-600. PubMed ID: 18239677
    [No Abstract]   [Full Text] [Related]  

  • 15. Facial granulomatous nodules during etanercept treatment for psoriasis.
    Samimi M; Lorette G; Machet L; de Muret A; Watier H; Maruani A
    Int J Dermatol; 2009 Sep; 48(9):1025-7. PubMed ID: 19703000
    [No Abstract]   [Full Text] [Related]  

  • 16. Psoriasiform and pustular eruption induced by etanercept and infliximab.
    Kuhara T; Watanabe D; Iwahori Y; Tamada Y; Yamamura M; Matsumoto Y
    Eur J Dermatol; 2009; 19(4):388-9. PubMed ID: 19467963
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed multiple injection site reaction in a rheumatoid arthritis patient treated with etanercept.
    Rajakulendran S; Deighton C
    Rheumatology (Oxford); 2004 Dec; 43(12):1588-9. PubMed ID: 15564639
    [No Abstract]   [Full Text] [Related]  

  • 18. Lichen planus associated with etanercept.
    Battistella M; Rivet J; Bachelez H; Lioté F
    Br J Dermatol; 2008 Jan; 158(1):188-90. PubMed ID: 17944978
    [No Abstract]   [Full Text] [Related]  

  • 19. Does prior treatment with fumaric acid esters predispose to tuberculosis in patients on etanercept?
    Ahmad K; McDonnell TJ; Rogers S
    Clin Exp Dermatol; 2007 May; 32(3):329. PubMed ID: 17397361
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists.
    Lamrock E; Brown P
    Australas J Dermatol; 2012 Nov; 53(4):e87-90. PubMed ID: 23157794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.